Choose HA†
Prescribing Information: DUROLANE, GELSYN-3, SUPARTZ FX
header-1

Specialty Pharmacies Help Make HA Therapies More Available and Affordable.

A specialty pharmacy can help your patients and your practice

You want your patients to have access to hyaluronic acid (HA) treatment options that will effectively treat their knee osteoarthritis (OA) pain. When you order our HA therapies through a specialty pharmacy, you give your patients that access—while incurring no financial overhead for your practice.

Benefits of using a specialty pharmacy:

  • More of your patients will have access to our HA therapies.
  • Patients may encounter fewer financial obstacles. (Out-of-pocket costs are often lower when using their insurance’s pharmacy benefit for HA therapies.)
  • You avoid overhead costs because you do not have to store and distribute the products.
  • The specialty pharmacy also can serve as a direct-purchase option for self-pay patients.

Preferred coverage for our HA portfolio

Our HA therapies are preferred by many major insurers.

Two simple options for using a specialty pharmacy to order our HA therapies.

Option 1:

  • Submit a benefit investigation through the MyBV360 portal, or submit an Osteoarthritis Enrollment form to the specialty pharmacy.
  • Once the treatment is approved, the specialty pharmacy will ship the product directly to you.
  • Schedule the patient’s appointment and administer the injection.

Discover the ease of MyBV360

The MyBV360 reimbursement services hub provides support with specialty pharmacy coordination and follow-up, benefit investigations, prior authorizations, real-time order status tracking, and more.

To learn more, visit Reimbursement Services.

Option 2:

  • Submit the prescription to the specialty pharmacy through electronic medical records (EMR), your payer prior authorization (PA) portal, or using HA enrollment forms.
  • The specialty pharmacy will complete the benefit investigation and support the PA process on your behalf.
  • After approval, the specialty pharmacy will collect the patient’s out-of-pocket costs and ship the product to your office for administration.

 

Our HA product portfolio

Use a specialty pharmacy to make our OA knee pain therapies more available and affordable for your patients—without incurring financial overhead for your practice.

Durolane Logo

DUROLANE single-injection HA:

  • Long-lasting by design, providing up to 6 months of pain relief10,24,32,35
  • Very high molecular weight HA, stabilized with a carefully controlled cross-linking process to increase residence time in the knee joint‡10,32,35,51
  • Proven to be noninferior to steroid at 6 weeks, in a Level 1 study§11
Choose DUROLANE
GELSYN3_RegisteredLogo

GELSYN-3 three-injection HA:

  • Features a consistent balance of molecular weight and viscosity for physician and patient satisfaction
  • It is proven to be clinically equivalent to higher molecular weight Synvisc||®9
  • Provides long-lasting relief, showing 60% reduction in knee pain at 26 weeks||¶9
Choose GELSYN-3
Supartz_centered_720x200

SUPARTZ FX five-injection HA:

  • Flexible, affordable dosing to meet all patient needs
  • A flexible, affordable option to meet a variety of patient needs
  • Over 520 million injections worldwide47
Choose SUPARTZ FX

How can we help you?

    I am a:













    ‡Very high molecular weight defined as >6000 kDa.

    §The primary outcome was the WOMAC pain responder rate at 12 weeks, defined as at least 40% relative improvement and 5-point absolute improvement from baseline values.11

    ||In the study by Pavelka et al., GELSYN-3 is called Sinovial.

    ¶WOMAC pain outcome, per protocol analysis

    Summary of Indications for Use: DUROLANE, GELSYN-3, and SUPARTZ FX are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.

    Contraindications and Summary of Risks: Do not inject DUROLANE, GELSYN-3, or SUPARTZ FX in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations.

    Risks can include transient pain or swelling at the injection site.

    DUROLANE, GELSYN-3, and SUPARTZ FX have not been tested in pregnant or lactating women, or children.

    Full prescribing information can be found in product labeling, at DUROLANE.com/IFU, GELSYN3.com/IFU, or SUPARTZFX.com/IFU, or Customer Service at 1-800-836-4080.

    Summary of Indications for Use:
    DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.

    Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site.

    DUROLANE has not been tested in pregnant or lactating women, or children.

    Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

    Summary of Indications for Use:
    GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

    GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

    Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

    Summary of Indications for Use:
    SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

    Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.